Heritage Wealth Management (Arizona)’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-15
Closed -$3K 939
2021
Q2
$3K Sell
15
-45
-75% -$7.72K ﹤0.01% 824
2021
Q1
$9K Buy
+60
New +$9.28K 0.01% 595

Other funds holding ALXN

Heritage Wealth Management (Arizona)'s ALXN Position: Q3 2021 in Review

Heritage Wealth Management (Arizona) sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 15 shares — an estimated $3K sold.

Heritage Wealth Management (Arizona) first reported a position in ALXN in Q1 2021 and held it in 2 quarters. The position peaked at $9K in Q1 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Heritage Wealth Management (Arizona) reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Heritage Wealth Management (Arizona) sold 15 Alexion Pharmaceuticals shares in Q3 2021, an estimated $3K.
  • Heritage Wealth Management (Arizona) first reported a position in Alexion Pharmaceuticals in Q1 2021 and held it in 2 quarters.
  • Heritage Wealth Management (Arizona)'s Alexion Pharmaceuticals position peaked at $9K in Q1 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Heritage Wealth Management (Arizona)'s 13F filing for Q3 2021, filed 10 Nov 2021.